Economic Burden of Osteoporosis in South Korea: Claim Data of the National Health Insurance Service from 2008 to 2011

Ha, Yong Chan; Kim, Ha Young; Jang, Sunmee; Lee, Yong Seuk; Kim, Tae Young

doi:10.1007/s00223-017-0320-1

Cited by 23 publications

(22 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…South Korea incurs 645 million dollars for direct costs and 647 million dollars for indirect costs (34). According to another study conducted in South Korean, this country also spends 5,125,585 dollars annually for outpatient treatment (21). The annual cost of outpatient treatment in Australia was reported to be 350 million dollars in 2008 for direct cost (16).…”

Section: Discussionmentioning

confidence: 99%

“…The twenty-eight articles selected for the study had been published between 1980 and 2018. Of all, 4 articles were from USA (27,28,29,32), three articles were from Canada (22,23,41), two articles were from South Korea (21,34), two articles were from Portugal (31,42) , and two articles were from Germany (1,26). In addition, there was one article from each of the countries of Belgium, China, (30,22,24,27,40), hip fracture had been investigated in all studies and was reported as a costly complication.…”

Section: Indirect and Direct Costsmentioning

confidence: 99%

“…Qiu et al's study estimated indirect costs such as early retirement and job loss (17), while Kim et al's study estimated the rate of lost productivity (34). Only Chang's study reported incremental costs of treatment (21). Since all the studies included patientlevel data, it was not useful to conduct sensitivity analysis.…”

Section: Indirect and Direct Costsmentioning

confidence: 99%

See 2 more Smart Citations

Economic Burden of Osteoporosis in the World: A Systematic Review

Kemmak

Rezapour

Jahangiri

et al. 2020

Preprint

View full text Add to dashboard Cite

Background Osteoporosis is a skeletal disease that is associated with a reduction in bone mass and microstructures and deterioration of bone tissue. It is also associated with an increased risk of fracture that is the most important complication of osteoporosis. Osteoporosis and consequent fractures not only have a major impact on the health and quality of life, but also impose a significant economic burden on the health system of countries. Objective Since the population of many countries around the world is aging, the incidence of fractures due to osteoporosis is increasing too. The knowledge about costs and economic aspects of osteoporosis plays an important role in making policies and planning measures for the prevention and management of this disease, hence, this study systematically investigated the available evidence on the costs associated with osteoporosis worldwide. Methods Considering language, year of publication, and the research question, electronic searches were conducted in multiple databases and different sources. After selecting articles based on inclusion and exclusion criteria, the data were extracted and the results were summarized. To prevent bias, the whole procedure was performed by three researchers. Results Of a total of 1989 papers, 28 papers were included in the study on the basis of inclusion criteria. Among the selected studies, 13 papers reported direct and indirect costs. Based on the data extracted from the mentioned studies, the mean age of people with osteoporotic fractures was 50 years, with the highest costs associated with hip fractures. Conclusion There is a paucity of studies investigating the burden of osteoporosis in the world. The available studies indicate a lack of standardization in the methodological approach of assessing the economic burden of this disease. It is necessary to highlight the importance of studies on osteoporosis to inform policymakers and enhance health care planning.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Indirect and Direct Costsmentioning

confidence: 99%

See 1 more Smart Citation

Economic Burden of Osteoporosis in the World: A Systematic Review

Kemmak

Rezapour

Jahangiri

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…This was because health care costs for osteoporosis patients with fractures predominantly comprised of hospitalization cost among 3 components of costs that also included outpatient and pharmacy costs. [ 40 , 41 ]…”

Section: Discussionmentioning

confidence: 99%

“…[ 10 , 13 , 21 , 35 ] Health care costs of osteoporosis patients with fracture were higher than those without fracture. Ha et al [ 40 ] reported that from 2008 to 2011, health care costs per patient with osteoporotic fractures were 1.8 time costs per patient without fractures. Indeed, health care costs are much higher in hip fracture.…”

Section: Discussionmentioning

confidence: 99%

Effect of improved medication adherence on health care costs in osteoporosis patients

et al. 2018

Self Cite

View full text Add to dashboard Cite

Osteoporosis is a chronic disease that requires continuous health care spending for pharmacotherapy and examinations. Osteoporotic fractures are a major economic burden. However, little is known about the economic effects of osteoporosis and osteoporotic fractures in Korea.The purpose of this study was to determine the predictors of osteoporosis-related health care costs and to evaluate the economic effects of fracture prevention through medication adherence among osteoporosis patients.Using the Korea National Health Insurance Claims Database (KNHICD), we identified osteoporosis patients aged 50 years and older from 2011 to 2012. Annual health care costs of osteoporosis were analyzed from the insurer's perspective and compared between patients with fractures and those without fractures. Adherents were defined as patients with a medication possession ratio of ≥80%. A generalized linear model (GLM) was used to estimate the predictors of osteoporosis-related health care costs.The major predictors of osteoporosis-related health care costs were age, medication adherence, and the occurrence of fractures (P < .001). The proportion of fractures among non-adherents was approximately 1.1 times the proportion among adherents. Health care costs per patient with fractures were 3.8 times the costs per patient without fractures. Patients with fractures had higher health care costs due to hospitalization and outpatient costs but lower pharmacy costs than non-adherents. We estimated that about $5 million of health insurance expenses could be saved annually if all non-adherents became adherents.Improved osteoporosis medication adherence can reduce osteoporosis-related health care costs by preventing fractures. Persistent pharmacotherapy for osteoporosis is necessary to prevent osteoporotic fractures and to reduce osteoporosis-related health care costs.

show abstract

Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review

Burden

Tanaka

et al. 2020

Osteoporos Int

View full text Add to dashboard Cite

While many clinical guidelines recommend screening for osteoporosis for early detection and treatment, there is great diversity in the case-finding strategies globally. We sought to compare case-finding strategies, focusing on the approaches used in European and Asian countries. This article provides an overview of the current case-finding strategies in the UK, Germany (including Austria and German-speaking regions of Switzerland), China, Japan, and Korea. We conducted a review of current treatment guidelines in each country and included expert opinions from key opinion leaders. Most countries define osteoporosis among patients with a radiographically identified fracture of the hip or the vertebrae. However, for other types of fractures, or in the absence of a fracture, varying combinations of risk-factor assessment and areal bone mineral density (aBMD) assessed by dual X-ray absorptiometry are used to define osteoporosis cases. A T-score ≤ − 2.5 is accepted to identify osteoporosis in the absence of a fracture; however, not all countries accept DXA alone as the sole criteria. Additionally, the critera for requiring clinical risk factors in addition to aBMD differ across countries. In most Asian countries, aBMD scanning is only provided beyond a particular age threshold. However, all guidelines recommend fracture risk assessment in younger ages if risk factors are present. Our review identified that strategies for case-finding differ regionally, particularly among patients without a fracture. More homogenized ways of identifying osteoporosis cases are needed, in both the Eastern and the Western countries, to improve osteoporosis case-finding before a fracture occurs. Case-finding in osteoporosis is essential to initiate treatment and minimize fracture risk. We identified differences in case-finding strategies between Eastern and Western countries. In the absence of a diagnosed fracture, varying combinations of risk factors and bone density measurements are used. Standardized case-finding strategies may help improve treatment rates.

show abstract

Economic Burden of Osteoporosis in South Korea: Claim Data of the National Health Insurance Service from 2008 to 2011

Cited by 23 publications

References 38 publications

Economic Burden of Osteoporosis in the World: A Systematic Review

Economic Burden of Osteoporosis in the World: A Systematic Review

Effect of improved medication adherence on health care costs in osteoporosis patients

Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review

Contact Info

Product

Resources

About